1550P Survival outcomes in phase I trial combining the STING agonist ulevostinag ± pembrolizumab in solid tumors (MK1454-001).
Saved in:
| Title: | 1550P Survival outcomes in phase I trial combining the STING agonist ulevostinag ± pembrolizumab in solid tumors (MK1454-001). |
|---|---|
| Authors: | Llop Serna, S.1 (AUTHOR), Jimenez Labaig, P.1 (AUTHOR), Micheletto, I.1 (AUTHOR), Rullan Iriarte, A.J.2 (AUTHOR), Ouali, K.3 (AUTHOR), Champiat, S.4 (AUTHOR), Romano, E.5 (AUTHOR), Bastien, E.6 (AUTHOR), Golan, T.7 (AUTHOR), Gomez-Roca, C.A.8 (AUTHOR), Perets, R.9 (AUTHOR), Wong, D.J.10 (AUTHOR), Harrington, K.J.11 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS926-S926. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 189419973 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1550P Survival outcomes in phase I trial combining the STING agonist ulevostinag ± pembrolizumab in solid tumors (MK1454-001). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Llop+Serna%2C+S%2E%22">Llop Serna, S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jimenez+Labaig%2C+P%2E%22">Jimenez Labaig, P.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Micheletto%2C+I%2E%22">Micheletto, I.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rullan+Iriarte%2C+A%2EJ%2E%22">Rullan Iriarte, A.J.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ouali%2C+K%2E%22">Ouali, K.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Champiat%2C+S%2E%22">Champiat, S.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Romano%2C+E%2E%22">Romano, E.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bastien%2C+E%2E%22">Bastien, E.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Golan%2C+T%2E%22">Golan, T.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gomez-Roca%2C+C%2EA%2E%22">Gomez-Roca, C.A.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Perets%2C+R%2E%22">Perets, R.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wong%2C+D%2EJ%2E%22">Wong, D.J.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Harrington%2C+K%2EJ%2E%22">Harrington, K.J.</searchLink><relatesTo>11</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS926-S926. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189419973 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2025.08.2181 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S926 Titles: – TitleFull: 1550P Survival outcomes in phase I trial combining the STING agonist ulevostinag ± pembrolizumab in solid tumors (MK1454-001). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Llop Serna, S. – PersonEntity: Name: NameFull: Jimenez Labaig, P. – PersonEntity: Name: NameFull: Micheletto, I. – PersonEntity: Name: NameFull: Rullan Iriarte, A.J. – PersonEntity: Name: NameFull: Ouali, K. – PersonEntity: Name: NameFull: Champiat, S. – PersonEntity: Name: NameFull: Romano, E. – PersonEntity: Name: NameFull: Bastien, E. – PersonEntity: Name: NameFull: Golan, T. – PersonEntity: Name: NameFull: Gomez-Roca, C.A. – PersonEntity: Name: NameFull: Perets, R. – PersonEntity: Name: NameFull: Wong, D.J. – PersonEntity: Name: NameFull: Harrington, K.J. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2025 Supplement 2 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 36 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |